Logo
x

Search

Subscribe Now

ophthalmology

Samsung Bioepis Initiates P-I Study of SB17 Proposed Biosimilar to Stelara (ustekinumab)

Samsung Bioepis Initiates P-I Study of SB17 Proposed Biosimilar to Stelara (ustekinumab)

  • March 2, 2021
RetinAI Collaborates with Novartis to Provide AI Solutions in Ophthalmology

RetinAI Collaborates with Novartis to Provide AI Solutions in Ophthalmology

  • December 8, 2020
Samsung Bioepis and Biogen Announce EMA Filing Acceptance of SB11 (biosimilar- ranibizumab)

Samsung Bioepis and Biogen Announce EMA Filing Acceptance of SB11 (biosimilar- ranibizumab)

  • October 7, 2020
Aerie Pharmaceuticals to Acquire Avizorex Pharma to Expand its Footprint in Ophthalmology

Aerie Pharmaceuticals to Acquire Avizorex Pharma to Expand its Footprint in Ophthalmology

  • November 18, 2019
Novartis Signs an Option Agreement with Iconic Therapeutics for its Ophthalmology Program

Novartis Signs an Option Agreement with Iconic Therapeutics for its Ophthalmology Program

  • August 23, 2019
Biogen to Acquire Nightstar Therapeutics for $800M

Biogen to Acquire Nightstar Therapeutics for $800M

  • March 4, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.